In this second discussion, Peter and Rita discuss the importance, new challenges, and best practices of personal and business leadership. What makes a good leader in a crisis? How can we be sure we are leading to the best of our abilities? And if we aren’t, how do we change and adapt?
As they explore lessons learned from navigating market disruption through client experiences, their own organizations, and as individual leaders, Rita and Pete will discuss why focus and remaining agile during and after a crisis are essential for success.
This full discussion covers more about how the COVID pandemic has challenged leadership and what we can do about it to ensure we are leading our teams, and our companies, to success in these challenging times. Some of the topics that will be explored during their discussion include:
What has the pandemic taught us about effective leadership during a crisis?
How can companies adapt their services in uncertain times?
How can leaders balance the need for agility with pre-existing and necessary governance processes?
How can leaders successfully steer their businesses through these and other transformative disruptions?
If you are an executive looking for practical advice on how to balance agility and governance processes this discussion will be of value to you.
Share this webinar!
Simply provide a few short details and you can watch this episode
About the speakers
About Rita Numerof and Numeroff & Associates
Rita E. Numerof, PhD, President of Numerof & Associates, is an internationally recognized consultant and author with more than 30 years of experience in the field of strategy development and execution, business model design, and market analysis. Numerof works globally with pharmaceutical and medical device manufacturers, payers, and providers to develop and implement strategic solutions responsive to today’s dynamic business environment. Numerof helps their clients meet the challenges of development and commercialization – including strategy, market access, health economics, stakeholder analysis and value narrative development, and market evaluation.
About Peter Hempshall and Deallus
Peter Hempshall is a career consultant and business leader. Over the past twelve years, Peter has successfully led a series of global companies and strategic business units, specializing in competitive intelligence; business insights; commercial strategy and market access. Peter cut his teeth in business strategy and leadership during the financial crisis of 2008. He became CEO of Deallus, a life sciences consulting firm with a strong heritage in competitive intelligence, in 2019. Deallus works closely with pharmaceutical and biotech companies in order to offer thought partnership and strategic intelligence that shapes and refines strategies for competitive advantage.
Upcoming topics in this discussion series
A look at what’s ahead in the Navigating Market Disruption series:
Maneuvering complex change in clinical trials
- Building supply chain capabilities for the changing marketplace
The long-term impacts of COVID-19 on commercial models and manufacturer relationships